Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
April 15, 2024
April 15, 2024
SANTA CLARA, California, April 15 -- Agilent Technologies, a company that specializes in life sciences, diagnostics and applied chemical markets, issued the following news release:
Agilent Technologies Inc. (NYSE: A) today announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demonstrates that the assay meets the higher standards established by IVDR. It ensures the continued availability of this trusted qualitative assa . . .
Agilent Technologies Inc. (NYSE: A) today announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demonstrates that the assay meets the higher standards established by IVDR. It ensures the continued availability of this trusted qualitative assa . . .